CHANGES OF THE SERUM ENZYME LEVEL IN PATIENTS WITH LIVER CARCINOMA by Rusinov, E. et al.
CHANGES OF T H E SERUM ENZYME L E V E L 
IN PATIENTS WITH L I V E R CARCINOMA 
E . Rus inov , G . Varbanov , R . Pa t eva , I . Danev 
K e y - w o r d s : se rum enzymes — l i v e r c a r c i n o m a — ex t rahepa t i c cholestasis — diagnosis 
Recently, the enzyme diagnostics of l iver diseases develops very intensively 
in the view of optimal use of enzyme sets and constellations for the needs of c l i -
nical practice. (3, 6—10). Concerning the acute and chronic l iver diseases there 
are relat ively a few enzymes only which have a greater diagnostic importance. 
Out of the cytoplasmic enzymes both S G O T and S G P T are most significant, out 
of cellular membrane ones the following enzymes have to be pointed: G G T P , 
A P , L A P and 5'-nudeotidase. A s regards the ergastoplasmic reticulum enzymes 
both cholinesterase and CP1 are considered to be most significant. 
Nowadays, the incidence of metastatic and primary liver carcinoma increa-
ses. As regards many European countries the patients wi th primary l iver carci-
noma are at an average about 2,5 % out of a l l cancer patients but in Bulgaria 
this percentage is 8,5 % . Concerning Varna city and, especially Bourgas district 
this ratio is considerably higher (up to 19 % ) . I n some African countries over 
80 % of malignant diseases are due to primary liver carcinoma (4, 5, 11, 16). Of 
course, the laparoscopy and the purposeful l iver biopsy are most important for diag-
nosis of hepatic carcinoma (2, 5, 11, 16), but they can't be performed in every 
one patient. That ' s why besides c l in ical examination the laboratory tests, espe-
c ia l ly of G G T P , S G O T , S G P T , A P , L A P and cholinesterase, play" an essential 
role in these cases. 
The so-called Weber's triad is described in patients wi th l iver carcinoma. 
I t consists of: 1, Increase of excretory cholestatic enzymes. G G T P increases com-
monly more that 20 times which is due to the cholestasis and to the intensive 
synthesis in surrounding parenchyma and even in neoplastic tissue (6, 8, 12, 14v 
15) A P is usually increased more than 10 times (6, 8, 13). L A P ac t iv i ty is more 
frequently positive than A P one and more rarely than G G T P one. (6, 8 ) . 
The increase of G G T P , A P and L A P is less expressed in cases of benign extra-
hepatic cholestasis (6, 8) . 2. A cytolysis and a necrosis wi th moderately increa-
sed S G O T and S G P T levels can be found out in most patients wi th l iver carcinoma 
( 1 , 8, 14, 17). 3. The reduced hepatic function is manifested wi th strongly dimi-
nished cholinesterase. I ts level decreases later and less expressed in the cases wi th 
metastatic than in those wi th primary l iver carcinoma (6, 8, 10, 14, 17). 
The aim of our work was to investigate the changes of serum enzymes in patients 
w i th l iver carc in)ma. 
Material and methods 
The serum enzymes were studied by using standard methods in the Central 
biochemical laboratory, Distr ict hospital, Varna c i ty . Enzyme levels are given 
according to S I bioconstants. The investigation covers 48 patients w i th l iver 
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carcinoma (primary and secondary). They were 25 males and 23 females 
aged between 23 and 75 years, at an average 57,5 years. 16 patients wi th choledo-
cholithiasis and extrahepatic cholestasis were also examined. They were 6 males 
and 10 females aged 26—74 years, at an average 55,2 years. As controls, 26 heal-
thy individuals (12 males and 14 females aged between 18 and 72 years, at an 
average 37,5 years) were also studied. A n y patients were either laparoscopically 
and, or laparotomically verified and then histologically examined. The variat ion 
analysis was used in statistical data processing. 
Results and discussion 
Table 1 demonstrates that levels of any serum enzymes ( G G T P , S G O T , 
S G P T , A P , and L A P ) are rel iably increased in patients wi th l iver carcinoma as 
T a b l e 1 
Patients' groups/ 
Enzymes 
Healthy Liver carcinoma 
x f m 
% increased 
enzyme levels 
G G T P 
S G O T 
S G P T 
A P 
L A P 








1 7 , 6 4 - 3 , 0 6 
1 0 , 0 8 - 1 , 4 6 
1 1 , 4 8 - 1 , 5 8 
3 2 , 9 6 - 2 , 3 9 
1 5 , 2 5 - 1,09 







4 2 0 . 2 - 44 ,06 
3 9 , 6 - 3,17 
4 0 , 7 3 - 4,18 
2 3 2 . 3 - 20,06 
4 9 , 3 - 8,13 
2 , 6 3 - 0 , 2 6 
< 0 , 0 0 1 
< 0 , 0 0 1 
< 0 , 0 0 1 
< 0 , 0 0 1 
< 0 , 0 0 1 







ompared wi th those of the controls. G G T P increase is most expressed — more 
han 20 times, followed by A P one (more than 7 times), L A P one (more than 3 
times) and both S G O T and S G P T ones (about 4 times). However, cholinesterase 
is reduced by approximately 40 %. Most frequently, G G T P , A P an L A P are 
changed. Our results coincide wi th those of many other authors ( 1 , 6, 8, 12—15, 
17). The comparison of serum enzyme levels in l iver carcinoma patients w i t h 
those of cases wi th extrahepatic choledocholithiatic cholestasis (see table 2 ) 
T a b l e 2 
Patients' groups/ 
Enzymes 
G G T P 
S G O T 
S G P T 
A P 
L A P 
C h o l i n -
esterase 







x + m 
5 0 1 , 5 - 6 5 , 6 
4 8 , 4 - 4 , 4 8 
4 8 , 4 - 6 , 3 7 
2 9 1 , 2 - 2 8 , 9 
5 7 , 2 - 1 5 , 6 










4 8 9 , 5 - 8 2 , 1 3 
48,9 — 7,50 
7 4 , 7 - 1 1 , 3 1 
2 0 2 , 5 - 2 5 , 8 4 
79,2 — 25,80 
2,25—"0,31 
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shows that there are reliable differences only of A P levels which are higher in l i ­
ver carcinoma patients while S G P T levels are lower. Some other investigators report 
similar data (6, 8) . The juxtaposition of serum enzyme levels in hepatic carcinoma pa­
tients wi th or without hyperbilirubinaemia (see table 3) demonstrates a statistically 
T a b l e 3 
Patients* groups/ 
Enzymes 
Liver carcinoma with Liver carcinoma with 
increased bilirubin normal bilirubin P 
n x ± m n x + m 
G G T P 
S G O T 
S G P T 
A P 
L A P 







5 0 1 , 5 - 6 5 , 6 
4 8 , 4 - 4 , 4 8 
4 8 , 7 ± 6 , 3 7 
2 9 1 , 2 - 2 8 , 9 
5 7 , 2 - 1 5 , 6 







3 2 1 , 5 - 4 7 , 7 0 
30,0_= 3,71 
3 1 , 7 - 4 ,96 
168,3—20.71 
41 ,3—10,34 
3, 1 - 0,30 
< 0 , 0 5 
< 0 , 0 l 
< 0 , 0 5 
< 0 , 0 1 
> 0 , 1 0 
> 0 , 1 0 
reliably higher ac t iv i ty of G G T P , S G O T , S G P T and A P in patients w i t h hyper­
bil irubinaemia while the changes of L A P and cholinesterase levels are statisti­
cal ly unsignificant. The more considerable changes of serum enzyme act iv i ty in 
l iver carcinoma patients wi th hyperbilirubinaemia are most probably due as 
wel l to the malignant process in hepatocytes, as to the cholestasis itself. Bearing 
in mind that hepatocytic G G T P ac t iv i ty is already increased at early carcino­
genesis stages, we accept that its isolated increase even before the appearance of 
hyperbilirubinaemia has, undoubtedly, a great diagnostic significance. 
On the basis of our study the following conclusions could be drawn: 
1. The excretory cholestatic enzymes ( G G T P , A P and L A P ) have the grea­
test diagnostic value in l iver carcinoma patients. They are increased in more than 
90 % of the cases while the changes of the act iv i ty of cholinesterase und transa­
minases are more unsignificant. 
2. There is no essential difference between the ac t iv i ty of serum enzymes 
in l iver carcinoma patients and that in choledocholithiatic cholestasis ones. 
That ' s why they can't be used as reliable test for differential diagnosis of malig­
nant and benign cholestasis. 
3. S G O T and S G P T ac t iv i ty is higher in advanced hepatic carcinoma pati­
ents w i th manifested jaundice as compared wi th those without icterus. 
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И З М Е Н Е Н И Я У Р О В Н Я С Ы В О Р О Т О Ч Н Ы Х Э Н З И М О В У Б О Л Ь Н Ы Х 
Р А К О М П Е Ч Е Н И 
Е . Русинов, Г. Варбанов, Пашева 
Р Е З Ю М Е 
А в т о р а м и и с с л е д о в а н ы э н з и м ы 48 б о л ь н ы х р а к о м п е ч е н и , 16 б о л ь н ы х д о б р о к а ч е с т в е н н ы м 
х о л е л и т и а з о м с э к с т р а г е п а т а л ь н ы м х о л е с т а з о м и 25 з д о р о в ы х л и ц . Н а и б о л ь ш е й д и а г н о с т и ­
ч е с к о й ц е н н о с т ь ю о т л и ч а ю т с я и з м е н е н и я а к т и в н о с т и Г Т Т П , А Ф и Л А П , п о в ы ш е н н ы х б о л е е 
чем у 90 % б о л ь н ы х р а к о м п е ч е н и . М е н ь ш у ю д и а г н о с т и ч е с к у ю ц е н н о с т ь и м е ю т с ы в о р о т о ч ­
н а я х о л е э с т е р а з а , а т а к ж е С Г О Т и С Г П Т . 
